Page 1

" Monash IVF Group Monash IVF Group Limited Appendix 4D Half year report ACN 169 302 309 Reporting period : Previous corresponding period : Release date : Half year ended 31 December 2020 Half year ended 31 December 2019 24 February 2021 Results for announcement to the market A $ ' 000 Revenue from ordinary activities Up 17.8 % to 90,775 Earnings before interest , tax , depreciation ( EBITDA ) ( 1 ) Up 57.7 % to 28,730 Earnings before interest and tax ( EBIT ) Up 71.0 % to 22,427 Adjusted Net profit from ordinary activities after tax attributable to members ( 2 ) ( 3 ) Up 30.5 % to 11,811 Net profit from ordinary activities after tax attributable to members Up 78.5 % to 14,558 ( 1 ) EBITDA is earnings before interest , tax , depreciation and amortisation . EBITDA is a non - IFRS measure which is used by the Group as a key indicator of underlying performance . This non - IFRS measure is not subject to audit or review . ( 2 ) Adjusted reflects non - regular items relating to pre - tax impact from JobKeeper Subsidy payments received from Q1FY2021 ( $ 5,058,000 ) , Acquisition earn - out fair value adjustment ( $ 200,000 ) and Sydney CBD fertility clinic commissioning costs ( $ 848,000 ) Refer to page 6 of the financial report . ( 3 ) Adjusted NPAT is a non - IFRS measure . Dividends Date paid payable Amount per security Franked amount per security Interim Dividend ( current reporting period ) 7 April 2021 2.1 ¢ 2.1 ¢ Interim Dividend ( previous 3 April 2020 2.1 ¢ 2.1 ¢ corresponding period ) Final Dividend year ending 30 June 2020 Record date for determining entitlements to the Final Dividend : 10 March 2021 Brief explanation : Please refer to the commentary in the review of operations and activities section of the Directors Report and the 1H21 Results Announcement accompanying this Financial Report .